News

In a compelling case that underscores the complexity of biologic therapies, a patient with hidradenitis suppurativa (HS) developed adalimumab-induced pustular psoriasis, which was successfully treated with guselkumab.

Trastuzumab deruxtecan combined with pertuzumab significantly delayed disease progression compared to standard care in patients with HER2-positive advanced breast cancer, according to initial findings from the DESTINY-Breast09 Phase III trial.

Breast cancer survivors may face a lower risk of Alzheimer’s disease than their cancer-free peers, according to a large retrospective cohort study examining long-term cognitive outcomes following treatment.

Digital inhaler metrics may offer an early signal of impending COPD exacerbations, according to a new pilot study evaluating real-world use of the ProAir Digihaler among high-risk patients.

A personalized approach to managing tuberculosis drug reaction with eosinophilia and systemic symptoms, or TB DRESS, is gaining momentum as clinicians face increasing challenges in treating tuberculosis in immunocompromised populations, particularly people living with HIV.

Vestibular dysfunction and impaired balance may be more common in patients with primary Sjogren’s syndrome than previously understood, according to new research exploring the condition’s neurological impact.

A population-based cohort study finds that asthma patients treated with dupilumab may face an increased risk of developing lymphoma, particularly T and natural killer (NK) cell subtypes, compared to those treated with standard combination inhalers.

Pro-inflammatory diets may increase the risk of death in patients with Stage III colon cancer, according to a new analysis of dietary patterns in a large cohort of U.S. patients.